Prevalence of plasmid mediated bla TEM-1 and bla CTX-M-15 type extended spectrum beta-lactamases in patients with sepsis

Asian Pacific Journal of Tropical Medicine

Volumn 5, Issue 2, 2012, Pages 98-102

  Haque, Shahzad F ^a   Ali, Saeedut Z ^b   TP, Mohammed ^a   Khan, Asad U ^b  

^a ALIGARH MUSLIM UNIVERSITY   (India)

^b ALIGARH MUSLIM UNIVERSITY   (India)

Author keywords

Antimicrobial resistance; ESBL; Gram negative sepsis

Indexed keywords

AMIKACIN; AMPICILLIN; BETA LACTAMASE CTX M; BETA LACTAMASE TEM 1; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLOXACILLIN; COTRIMOXAZOLE; ERTAPENEM; EXTENDED SPECTRUM BETA LACTAMASE; GATIFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; NALIDIXIC ACID; PENICILLIN G; TETRACYCLINE; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONJUGATION; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTERIACEAE; ESCHERICHIA COLI; GENE AMPLIFICATION; GRAM NEGATIVE SEPSIS; HORIZONTAL GENE TRANSFER; KLEBSIELLA; MOLECULAR EPIDEMIOLOGY; MOLECULAR MECHANICS; NONHUMAN; OBSERVATIONAL STUDY; OPEN STUDY; PLASMID; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSEUDOMONAS;

ANTI-INFECTIVE AGENTS; BACTEREMIA; BETA-LACTAMASES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; INDIA; KLEBSIELLA; KLEBSIELLA INFECTIONS; MALE; MIDDLE AGED; MOLECULAR EPIDEMIOLOGY; PLASMIDS; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDIES; PSEUDOMONAS;

EID: 84855319407     PISSN: 19957645     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1995-7645(12)60003-0     Document Type: Article

References (31)

1. Shakil S, Khan R, Zarrilli R, Khan AU Aminoglycosides versus bacteria-a description of the action, resistance mechanism and nosocomial battleground. J Biomed Sci 2008, 15:5-14.
2. Paterson DL, Bonomo RA Extended-spectrum b-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
3. Pfaller MA, Segreti J Overview of the epidemiological profile and laboratory detection of extended-spectrum b-lactamases. Clin Infect Dis 2006, 42:S153-S163.
4. Ma L, Lin CJ, Chen JH, Fung CP, Chang FY, Lai YK, et al. Widespread dissemination of aminoglycoside resistance genes, Klebsiellapne pumoniae isolates in Taiwan producing CTX-M-type extended-spectrum β-lactamases. Antimicrob Agents Chemother 2009, 53:104-111.
5. Shakil S, Ali SZ, Akram M, Khan AU Risk factors for extended-spectrum blactamaseproducing Escherichia coli and Klebsiella pneumonia acquisition in a neonatal intensive care unit. J Trop Pediatr 2010, 56:90-96.
6. Wright GD Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv Drug Deliv Rev 2005, 57:1451-1470.
7. Gazouli M, Tzelepi E, Markogiannakis A, Legakis NJ, Tzouvelekis LS Two novel plasmid-mediated cefotaxime-hydrolyzing β-lactamases (CTX-M-5 and CTX-M-6) from Salmonella typhimurium. FEMS Microbiol Lett 1998, 165:289-293.
8. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, et al. Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis 2010, 50:40-48.
9. Rodriguez-Baño J, Navarro MD, Romero L, Muniain MA, de Cueto M, Ríos MJ, et al. Bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli in the CTX-M era: a new clinical challenge. Clin Infect Dis 2006, 43:1407-1414.
10. Akram M, Shakil S, Khan AU Prevalence of integrons, blaCTX-M and blaTEM resistance markers among ESBL-producing uropathogenic Escherichia coli isolates: first report of genomic blaCTX-M from India. J Chemother 2011, 23:131-134.
11. Akram M, Shahid M, Khan AU Etiology andantibiotic resistance patterns of community-acquired urinary tract infections in JNMC Hospital Aligarh, India. Ann Clin Microbiol Antimicrob 2007, 6:4.
12. Sutter VL, Citron DM, Edelstein MAC, Finegold SM Wadsworth anaerobic bacteriology manual 1985, Star Publishing, Belmont CA. 4th ed.
13. Clinical and laboratory standards institute Performance standards for antimicrobial susceptibility testing; nineteenth informational supplement. Document M100-S19 2009, CLSI, Wayne PA.
14. Birnboim HC, Doly J A rapid alkaline extraction procedure for screening recombinant plasmid DNA. Nucleic Acids Res 1979, 7:1513-1523.
15. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-van Dillen PME, van der Noordaa J Rapid and simple method for purification of nucleic acid. J Clin Microbiol 1990, 28:495-503.
16. Versalovic J, Koeuth T, Lupski JR Distribution of repetitive DNA sequences in eubacteria and application to fingerprinting of bacterial genomes. Nucl Acids Res 1991, 19:6823-6831.
17. Gray KJ, Wilson LK, Phiri A, Corkill JE, French N, Hart CA Identification and characterization of ceftriaxone resistance and extended-spectrum β-lactamases in Malawian bacteraemic Enterobacteriaceae. J Antimicrob Chemother 2006, 57:661-665.
18. Suarez CJ, Lolans K, Villegas MV, Quinn JP Mechanisms of resistance to beta-lactams in some common Gram-negative acteria causing nosocomial infections. Expert Rev Anti Infect Ther 2005, 3:915-922.
19. Goossens H, Grabein B Prevalence and antimicrobial susceptibility data for extended-spectrum beta-lactamase- and AmpC-producing Enterobacteriaceae from the MYSTIC Program in Europe and the United States (1997-2004). Diagn Microbiol Infect Dis 2005, 53:257-264.
20. Luzzaro F, Viganò EF, Fossati D, Grossi A, Sala A, Sturla C, et al. Prevalence and drug susceptibility of pathogens causing bloodstream infections in northern Italy: a two-year study in 16 hospitals. Eur J Clin Microbiol Infect Dis 2002, 21:849-855.
21. Taylor GD, Buchanan-Chell M, Kirkland T, McKenzie M, Wiens R Nosocomial urosepsis: Analysis of 218 cases. Int J Infect Dis 1996, 1:92-94.
22. Feldman C, Ross S, Mahomed AG, Omar J, Smith C The aetiology of severe community-acquired pneumonia and its impact on initial, empiric, antimicrobial chemotherapy. Respiratory Med 1995, 89:187-192.
23. Kumari HB, Nagarathna S, Chandramuki A Antimicrobial resistance pattern among aerobic gram-negative bacilli of lower respiratory tract specimens of intensive care unit patients in a neurocentre. Indian J Chest Dis Allied Sci 2007, 49:19-22.
24. Paterson DL, Bonomo RA Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev 2005, 18:657-686.
25. Canton R, Novais A, Valverde A, Machado E, Peixe L, Baquero F, et al. Prevalence and spread of extended-spectrum β-lactamase-producing Enterobacteriaceae in Europe. Clin Microbiol Infect 2008, 14:144-153.
26. Livermore DM, hawkey PM CTX-M: changing the face of ESBls in the UK. J Antimicrob Chemother 2005, 56:451-454.
27. Eckert C, Gautier V, Arlet G DNA sequence analysis of the genetic environment of various blaCTX-M genes. J Antimicrob Chemother 2006, 57:14-23.
28. Walsh TR, Toleman A, Jones RN Comment on: Occurrence, prevalence and genetic environment of CTX-M â-lactamases in Enterobacteriaceae from Indian hospitals. J Antimicrob Chemother 2007, 59:799-800.
29. Cantón R, Coque TM The CTX-M β-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475.
30. Eshwarappa M, Dosegowda R, Vrithmani Aprameya I, Khan MW, Shiva Kumar P, Kempegowda P Clinico-microbiological profile of urinary tract infection in South India. Indian J Nephrol 2011, 21:30-36.
31. Mendonca N, Leitao J, Manageiro V, Ferreira E Spread of extended-spectrum lactamase CTX-M-producing Escherichia coli clinical isolates in community and nosocomial environments in Portugal. Antimicrobial Agents Chemother 2007, 51:1946-1955.